Tsumura & Co operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tsumura & Co with three other
companies in this sector in Japan:
KYORIN Holdings, Incorporation
sales of 110.64 billion Japanese Yen [US$1.00 billion]
of which 95%
was Pharmaceutical Business),
Mochida Pharmaceutical Company Limited
(106.76 billion Japanese Yen [US$966.19 million]
of which 100%
was Pharmaceutical Business), and
Nippon Shinyaku Co Ltd
(101.45 billion Japanese Yen [US$918.10 million]
of which 86%
was Pharmaceutical Products).
Tsumura & Co reported sales of ¥117.88 billion (US$1.07 billion)
March of 2018.
increase of 2.5%
versus 2017, when the company's sales were ¥114.95 billion.
Sales at Tsumura & Co have increased during each of the previous five years
(and since 2013, sales have increased a total of 12%).